NCT00040755View on ClinicalTrials.gov

BMS-275291 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

PHASE2CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

May 31, 2002

Primary Completion Date

July 31, 2006

Conditions
Adenocarcinoma of the ProstateBone MetastasesHormone-resistant Prostate CancerRecurrent Prostate CancerStage IV Prostate Cancer
Interventions
DRUG

rebimastat

Given orally

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

95817

UC Davis Comprehensive Cancer Center, Sacramento

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00040755 - BMS-275291 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy | Biotech Hunter | Biotech Hunter